Randomized double‐blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites

Background:  The clinical efficacy of sublingual immunotherapy (SLIT) in mite allergy and in mild disease is still a matter of debate, thus we performed a long‐term clinical trial.

[1]  S. Durham,et al.  Sublingual immunotherapy for allergic rhinitis , 2010 .

[2]  G. Canonica,et al.  Pharmacokinetics of Der p 2 Allergen and Derived Monomeric Allergoid in Allergic Volunteers , 2005, International Archives of Allergy and Immunology.

[3]  G. Passalacqua,et al.  Post‐marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  G. Canonica,et al.  Quantitative assessment of the adherence to sublingual immunotherapy. , 2004, The Journal of allergy and clinical immunology.

[5]  T. Holland-Letz,et al.  Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double‐blind placebo‐controlled study , 2004, Allergy.

[6]  R. Puy,et al.  Allergen immunotherapy for asthma. , 2003, The Cochrane database of systematic reviews.

[7]  G. Canonica,et al.  Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy , 2003, Allergy.

[8]  N. Canitano,et al.  Immunomodulation during sublingual therapy in allergic children , 2003, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[9]  J. Colin,et al.  House‐dust mite sublingual‐swallow immunotherapy in perennial conjunctivitis: a double‐blind, placebo‐controlled study , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  G. Canonica,et al.  Noninjection routes for immunotherapy. , 2003, The Journal of allergy and clinical immunology.

[11]  J. Bousquet,et al.  Allergic rhinitis and its impact on asthma. , 2001, The Journal of allergy and clinical immunology.

[12]  L. Klimek,et al.  Generic or disease‐specific quality of life scales to characterize health status in all_ergic rhinitis? , 2001, Allergy.

[13]  E. Meltzer,et al.  Quality of life in adults and children with allergic rhinitis. , 2001, The Journal of allergy and clinical immunology.

[14]  G. Canonica,et al.  Quality of life in respiratory allergy. , 2001, Allergy and asthma proceedings.

[15]  G. Ciprandi,et al.  Health‐related quality of life assessment in young adults with seasonal allergic rhinitis , 2001, Allergy.

[16]  H. Malling.  Allergen-specific immunotherapy in allergic rhinitis , 2001, Current opinion in allergy and clinical immunology.

[17]  L. Morabito,et al.  Clinical and immunologic effects of long‐term sublingual immunotherapy in asthmatic children sensitized to mites:a double‐blind, placebo‐controlled study , 2000, Allergy.

[18]  C. André,et al.  House‐dust‐mite sublingual‐swallow immunotherapy (SLIT) in perennial rhinitis: a double‐blind, placebo‐controlled study , 2000, Allergy.

[19]  Anna Giardini,et al.  A New Instrument in Quality-of-Life Assessment: The Satisfaction Profile (SAT-P) , 1999 .

[20]  J. Bousquet,et al.  Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. , 1999, The Journal of allergy and clinical immunology.

[21]  D. Caillaud,et al.  Sublingual‐swallow immunotherapy (SLIT) in patients with asthma due to house‐dust mites: a double‐blind, placebo‐controlled study , 1999, Allergy.

[22]  J Bousquet,et al.  Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.

[23]  S. Taylor,et al.  Food science perspective on food allergy , 1998, Allergy.

[24]  G. Canonica,et al.  Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis , 1998, The Lancet.

[25]  T. Hirsch,et al.  Double‐blind placebo‐controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children , 1997, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[26]  G. Mistrello,et al.  Monomeric chemically modified allergens: immunologic and Physicochemical characterigation , 1996, Allergy.

[27]  R. Lockey,et al.  Survey of fatalities from skin testing and immunotherapy 1985-1989. , 1993, The Journal of allergy and clinical immunology.

[28]  L. R. Twentyman.  On asthma , 1985, British Homeopathic Journal.

[29]  T. Bianchi.  Riflessioni sulle considerazioni finali del Governatore della banca d'Italia , 1994 .